The overexpression of NEK2 in lung cancer patients compared with that in normal subjects has been reported, and the upregulation of NEK2 is related to poor overall survival, relapse-free survival, and increased risk of recurrence [105]. This evidence concerns the gene NEK2 and lung carcinoma.